Immobilized lactoferrin (Lf) stimulates eosinophil superoxide (O2) production and release of eosinophil-derived neurotoxin (EDN).

被引：0
|
作者：
Thomas, LL
Xu, W
Ardon, TT
机构：
[1] Rush Univ, Chicago, IL 60612 USA
[2] Beloit Coll, Beloit, WI 53511 USA
来源：
FASEB JOURNAL | 2002年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1238 / A1239
页数：2
相关论文
共 50 条
  • [31] Evaluation of serum (S) and urinary (U) eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN) as biomarkers of eosinophilic (Eo) acute exacerbation of chronic obstructive pulmonary disease (AE)
    Schlesser, Charlotte
    Jadot, Ines
    Marchand, Eric
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [32] Mobilization of various types of leukocytes by human granulocyte-derived antimicrobial proteins:: Identification of novel activities and/or receptors for defensins, cathelicidin, and eosinophil-derived neurotoxin (EDN)
    Yang, D
    Chertov, O
    Rosenberg, HF
    Chen, Q
    Anderson, M
    Schröder, JM
    Oppenheim, JJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 2000, : 20 - 20
  • [33] C/EBP regulates the promoter of the eosinophil-derived neurotoxin/RNS2 gene in human eosinophilic cells
    Baltus, B
    Buitenhuis, M
    van Dijk, TB
    Vinson, C
    Raaijmakers, JAM
    Lammers, JWJ
    Koenderman, L
    de Groot, RP
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (04) : 683 - 688
  • [34] Crystal structures of eosinophil-derived neurotoxin (EDN) in complex with the inhibitors 5′-ATP, Ap3A Ap4A and Ap5A
    Baker, MD
    Holloway, DE
    Swaminathan, GJ
    Acharya, KR
    BIOCHEMISTRY, 2006, 45 (02) : 416 - 426
  • [35] Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and intron
    Tiffany, HL
    Handen, JS
    Rosenberg, HF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12387 - 12393
  • [36] Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus
    Domachowske, JB
    Dyer, KD
    Bonville, CA
    Rosenberg, HF
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06): : 1458 - 1464
  • [37] Functional role of type II secretory PLA2 (sPLS2) and type V sPLA2 on release of eosinophil-derived neurotoxin (EDN) and LTC4 synthesis from activated eosinophils.
    Muñoz, NM
    Kim, K
    Han, S
    Cho, W
    Leff, AR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A465 - A465
  • [38] The role of transcription factor PU.I in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene
    van Dijk, TB
    Caldenhoven, E
    Raaijmakers, JAM
    Lammers, JWJ
    Koenderman, L
    de Groot, RP
    BLOOD, 1998, 91 (06) : 2126 - 2132
  • [39] Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence
    Handen, JS
    Rosenberg, HF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1665 - 1669
  • [40] The synthetic PPARγ agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils
    Matsuwaki, Y
    Ueki, S
    Adachi, T
    Oyamada, H
    Kamada, Y
    Yamaguchi, K
    Kanda, A
    Hamada, K
    Kayaba, H
    Chihara, J
    PHARMACOLOGY, 2005, 74 (04) : 169 - 173
12345